What the research examined
The STEP 1 extension followed a subset of trial participants after the study intervention ended. Investigators observed weight regain and movement of several cardiometabolic measures toward baseline. The report examines the durability of changes beyond the active trial period.
How to interpret the findings
An extension cohort is a selected subset of the original trial, and follow-up conditions differ from the randomized treatment period. These observations describe a study population; they are not instructions for starting, stopping, or changing treatment.
Research literature
- Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1 trial extension.
Diabetes, obesity & metabolism · 2022 · PMID 35441470
Links open the indexed paper records. Summaries are based on those records and their available abstracts, not a systematic review or a full-text appraisal of every study.